| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the Treatment of Hepatitis C
|
Parry, Nicola
|
|
2014
|
|
51 |
p. 19-20
|
artikel
|
| 2 |
APR Improves PsA Symptoms Out to Week 104
|
Vinall, Maria
|
|
2014
|
|
51 |
p. 12-13
|
artikel
|
| 3 |
Efficacy of Secukinumab Sustained over Time for Treatment of Active PsA
|
Nierengarten, Mary Beth
|
|
2014
|
|
51 |
p. 14-15
|
artikel
|
| 4 |
Flare-Free Withdrawal of TNFis Possible in Patients with RA and Stable Low Disease Activity
|
Parry, Nicola
|
|
2014
|
|
51 |
p. 11-12
|
artikel
|
| 5 |
FUTURE 1: Secukinumab Inhibits Radiographic Disease Progression in PsA
|
Nierengarten, Mary Beth
|
|
2014
|
|
51 |
p. 15-17
|
artikel
|
| 6 |
Gout Guidelines: The Good, the Bad, and the Future
|
Shuman, Jill
|
|
2014
|
|
51 |
p. 21-23
|
artikel
|
| 7 |
GR Agonist Improves Responses in RA
|
Kuznar, Wayne
|
|
2014
|
|
51 |
p. 8-9
|
artikel
|
| 8 |
Guidelines for PMR Favor Lowest Effective Dose of GCs as Initial Therapy
|
Kuznar, Wayne
|
|
2014
|
|
51 |
p. 26-27
|
artikel
|
| 9 |
Infliximab Biosimilar Appears Safe and Effective Compared with Infliximab for RA
|
Shuman, Jill
|
|
2014
|
|
51 |
p. 11-11
|
artikel
|
| 10 |
Lesinurad Provides Additional Lowering of SUA in Gout
|
Kuznar, Wayne
|
|
2014
|
|
51 |
p. 10-10
|
artikel
|
| 11 |
MEASURE 1: Secukinumab an Effective Treatment for Active AS
|
Vinall, Maria
|
|
2014
|
|
51 |
p. 18-18
|
artikel
|
| 12 |
Negative Results End Development Program of Treating JIA with GLM
|
Nierengarten, Mary Beth
|
|
2014
|
|
51 |
p. 17-18
|
artikel
|
| 13 |
New Approaches to Corticosteroid Resistance
|
Vinall, Maria
|
|
2014
|
|
51 |
p. 4-5
|
artikel
|
| 14 |
New Approaches to Treating LN
|
Vinall, Maria
|
|
2014
|
|
51 |
p. 24-25
|
artikel
|
| 15 |
Preventing GC-Induced Bone Loss in Women with RA
|
Shuman, Jill
|
|
2014
|
|
51 |
p. 9-9
|
artikel
|
| 16 |
Secukinumab is Effective Treatment for Active PsA
|
Nierengarten, Mary Beth
|
|
2014
|
|
51 |
p. 6-6
|
artikel
|
| 17 |
Sifalimumab Slows Disease Activity in SLE
|
Kuznar, Wayne
|
|
2014
|
|
51 |
p. 7-8
|
artikel
|
| 18 |
Triple Therapy More Cost-effective than Biologic First in Patients Who Fail MTX
|
Nierengarten, Mary Beth
|
|
2014
|
|
51 |
p. 13-14
|
artikel
|
Tijdschrift beschrijving